SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010684
Filing Date
2019-11-12
Accepted
2019-11-12 07:41:33
Documents
79
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20190930x10q.htm 10-Q 2812307
2 EX-10.1 ocul-20190930ex1015fdbd5.htm EX-10.1 94176
3 EX-10.2 ocul-20190930ex10267316e.htm EX-10.2 64588
4 EX-31.1 ocul-20190930ex31109263e.htm EX-31.1 14595
5 EX-31.2 ocul-20190930ex312b5b393.htm EX-31.2 10173
6 EX-32.1 ocul-20190930ex321fa9adf.htm EX-32.1 7091
7 EX-32.2 ocul-20190930ex3229b2532.htm EX-32.2 6720
  Complete submission text file 0001558370-19-010684.txt   7666635

Data Files

Seq Description Document Type Size
8 EX-101.INS ocul-20190930.xml EX-101.INS 1331531
9 EX-101.SCH ocul-20190930.xsd EX-101.SCH 47542
10 EX-101.CAL ocul-20190930_cal.xml EX-101.CAL 56824
11 EX-101.DEF ocul-20190930_def.xml EX-101.DEF 164832
12 EX-101.LAB ocul-20190930_lab.xml EX-101.LAB 368192
13 EX-101.PRE ocul-20190930_pre.xml EX-101.PRE 331785
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 191206130
SIC: 2834 Pharmaceutical Preparations